Meet our second disruptor Ignacio Muñoz-Sanjuán. Find out how Ignacio’s work is enabling organizations to develop novel therapies for Huntington’s disease. Through his drug discovery work at CHDI Foundation, a nonprofit organization, Ignacio fuels his motivation to uncover potential treatments and an eventual cure for this crippling transgenerational disease by partnering with multiple organizations with different technical expertise, like Charles River.
Find the link to the interview here
Factor-H ‘La Luz’ Caregivers program wins the 2024 Amgen/MIT Solve award at the Concordia Summit We are extremely honored and
We are honored to be 1 of 5 finalist nonprofit organizations being nominated for this prestigious award, selected out of
Yesterday, Uniqure reported on the 24-month results of their Phase 1/2 clinical trial with AMT-130, a viral gene therapy trial
Factor-H is a registered 501-(c)3 non-profit foundation in the United States (EIN 82-5395108)
English 
Spanish 
Portuguese